Biocon Q4FY25 results: Net profit jumps 153% YoY to Rs 344 crore; revenue rises 12% to Rs 4,454 crore
Biocon Limited reported a strong financial performance for the quarter and financial year ended March 31, 2025. For Q4FY25, consolidated revenue came in at Rs 4,454 crore, marking a 12% year-on-year (YoY) increase. On a like-for-like basis, the revenue grew 15% YoY after adjusting for revenues from Branded Formulations India (BFI).
EBITDA rose 16% YoY to Rs 1,115 crore with an EBITDA margin of 25%. Core EBITDA, excluding R&D and other adjustments, came in at Rs 1,363 crore with a margin of 31%.
The company posted a net profit of Rs 344 crore in Q4FY25, a significant 153% YoY jump. On a like-for-like basis, the net profit rose 162% YoY. Profit before tax (PBT) surged 53% YoY to Rs 487 crore. Segmental performance Generics : Revenue rose 46% YoY to Rs 1,048 crore, driven by strong contributions from Lenalidomide and Dasatinib launches in the U.S.
: Revenue rose 46% YoY to Rs 1,048 crore, driven by strong contributions from Lenalidomide and Dasatinib launches in the U.S. Biosimilars : Revenue increased 4% YoY to Rs 2,463 crore. On an adjusted basis, it rose 9% YoY.
: Revenue increased 4% YoY to Rs 2,463 crore. On an adjusted basis, it rose 9% YoY. Research Services (Syngene): Revenue climbed 11% YoY to Rs 1,018 crore. Full-year FY25 highlights
For the full year, Biocon reported: Total revenue : Rs 16,470 crore, up 5% YoY (8% like-for-like)
: Rs 16,470 crore, up 5% YoY (8% like-for-like) EBITDA : Rs 4,374 crore, up 5% YoY
: Rs 4,374 crore, up 5% YoY Net profit: Rs 1,013 crore, down 1% YoY; however, like-for-like net profit increased 30% Dividend and capital plans
The Board recommended a final dividend of Rs 0.50 per share. Additionally, it approved raising up to Rs 4,500 crore through various financial instruments for debt repayment and strategic investments. Strategic developments
Biocon Biologics launched its fifth biosimilar, Yesintek (bUstekinumab), in the U.S. and Germany, and secured a U.S. market entry for Yesafili (bAflibercept). The company also partnered with Civica Inc. to increase access to insulins.
Syngene crossed Rs 1,000 crore in quarterly revenue for the first time and acquired a biologics manufacturing facility in the U.S., expanding its CDMO capabilities.
Biocon has also initiated an evaluation of a potential merger between Biocon Limited and Biocon Biologics. Sustainability
Biocon and Biocon Biologics were both included in the S&P Global Sustainability Yearbook 2025, with Biocon ranked among the top 5% in the Biotechnology sector.
News desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
9 hours ago
- Business Upturn
IEX Q1 Results: Revenue rises 14.7% to Rs 141.75 crore, Net profit jumps 25% YoY
Indian Energy Exchange (IEX) reported a robust set of numbers for the quarter ended June 30, 2025 (Q1 FY26), with consolidated profit after tax (PAT) rising 25% year-on-year to Rs 120.7 crore, up from Rs 96.4 crore in Q1 FY25. The consolidated revenue grew 19% YoY to Rs 184.2 crore during the quarter. Electricity volume traded on the exchange stood at 32.4 billion units (BU), marking a 15% YoY growth, while the volume of Renewable Energy Certificates (RECs) traded surged 149% YoY to 52.7 lakh units. On a standalone basis, IEX reported a PAT of Rs 113 crore, up 21% from Rs 93.4 crore in the same quarter last year. Despite initial concerns over summer demand, an early monsoon and unseasonal rains led to a lower-than-expected peak power demand. The average Day-Ahead Market (DAM) price dropped 16% YoY to Rs 4.41/unit, while the Real-Time Market (RTM) price declined 20% YoY to Rs 3.91/unit due to improved liquidity and higher renewable supply. The Indian Gas Exchange (IGX), a wholly owned subsidiary of IEX, also recorded strong growth, with gas volumes at 24.6 million MMBtu, up 109% YoY. IGX PAT rose 86.7% YoY to Rs 14.1 crore. Another subsidiary, the International Carbon Exchange (ICX), issued over 44 lakh I-RECs in Q1 FY26, with revenue at Rs 1.79 crore. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
10 hours ago
- Business Upturn
EPACK Durable signs joint venture with Korea's Bumjin Electronics to manufacture TV and smart speakers in India
By Aditya Bhagchandani Published on July 24, 2025, 17:26 IST EPACK Durable Limited has entered into a strategic joint venture agreement with Bumjin Electronics Co. Limited, a company based in the Republic of Korea, to manufacture and sell a range of advanced audio products including television speakers, soundbars, AI speakers, Bluetooth speakers, and smart speakers. As per the agreement executed on July 24, 2025, EPACK Durable will hold a 66.67% stake in the joint venture company (JV Co.), while Bumjin will own the remaining 33.33%. The JV is initially focused on the Indian market with potential for international expansion. The new entity will have an initial authorised share capital of Rs 14 crore, with 1.4 crore equity shares of Rs 10 each. The business aims to cater to both online and offline sales channels, including e-commerce platforms, while leveraging both companies' strengths. Key operational appointments include the business head being nominated by EPACK, the technical head by Bumjin, and the finance head jointly selected. The JV is expected to support import substitution, boost domestic value addition, and allow technology transfer, making it a strategic move in India's growing smart electronics and home entertainment ecosystem. This partnership aligns with EPACK's expansion plans in electronics manufacturing and is expected to enhance its product portfolio and brand visibility in the consumer electronics segment. Upon investment, the JV Co. will become a subsidiary of EPACK Durable. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
12 hours ago
- Business Upturn
RailTel secures Rs 10 crore IT solutions order from Odisha government
By Aditya Bhagchandani Published on July 24, 2025, 15:46 IST RailTel Corporation of India Ltd has received a major order worth Rs 10.05 crore from the Department of Social Security and Empowerment of Persons with Disabilities (SSEPD), Government of Odisha. The work order pertains to the implementation of comprehensive IT solutions for the SSEPD Department and is to be executed by January 20, 2026. This order, disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015, marks another significant domestic contract for RailTel. The project is classified as a domestic work order and not a related party transaction. According to the filing, RailTel clarified that neither its promoter group nor any group companies have any interest in the awarding entity. The contract was formally received on July 24, 2025, at 11:53 AM. The company continues to expand its footprint in government-led digital transformation projects, leveraging its expertise in IT and telecom infrastructure. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
